Minhe Shen
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 17
- Cancer Immunotherapy and Biomarkers 5
- Cancer Cells and Metastasis 5
- Colorectal Cancer Treatments and Studies 3
-
- Metabolomics and Mass Spectrometry Studies 2
- Co-authors
- Shanming Ruan (32 shared papers)Leitao Sun (17 shared papers)Harpreet Wasan (10 shared papers)Jieru Yu (6 shared papers)Leyin Zhang (6 shared papers)Fangfang Tao (5 shared papers)Kaibo Guo (11 shared papers)Kai Zhang (9 shared papers)
- Journals
- Evidence-based Complementary and Alternative Medicine (4 papers)Frontiers in Oncology (3 papers)BioMed Research International (2 papers)Journal of Cancer (2 papers)Cancer Medicine (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Minhe Shen
35 papers receiving 738 citations
Peers
Comparison fields: 5 of 90
- Geriatrics and Gerontology 41
- Cancer Research 155
- Oncology 250
- Immunology 87
- Pharmacology 33
Countries citing papers authored by Minhe Shen
This map shows the geographic impact of Minhe Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minhe Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minhe Shen more than expected).
Fields of papers citing papers by Minhe Shen
This network shows the impact of papers produced by Minhe Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minhe Shen. The network helps show where Minhe Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside Minhe Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 142 | |
| 2 | 2019 | 78 | |
| 3 | 2018 | 74 | |
| 4 | 2020 | 53 | |
| 5 | 2020 | 36 | |
| 6 | 2012 | 28 | |
| 7 | 2019 | 26 | |
| 8 | 2021 | 25 | |
| 9 | 2021 | 21 | |
| 10 | 2016 | 18 | |
| 11 | 2017 | 17 | |
| 12 | 2019 | 16 | |
| 13 | 2018 | 16 | |
| 14 | 2019 | 14 | |
| 15 | 2019 | 14 | |
| 16 | 2019 | 14 | |
| 17 | 2021 | 13 | |
| 18 | 2020 | 13 | |
| 19 | 2019 | 13 | |
| 20 | 2014 | 13 |
About Minhe Shen
Minhe Shen is a scholar working on Oncology, Molecular Biology, Cancer Research, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 742 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Cancer Cells and Metastasis (5 papers), Cancer-related molecular mechanisms research (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer, Lipids, and Metabolism (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). The work is most often cited by research in Geriatrics and Gerontology (41 citations), Cancer Research (155 citations), Oncology (250 citations), Immunology (87 citations) and Pharmacology (33 citations). Minhe Shen has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Shanming Ruan, Leitao Sun, Harpreet Wasan, Jieru Yu, Leyin Zhang, Fangfang Tao, Kaibo Guo, Kai Zhang, Yuan Li and Shengliang Qiu. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, Frontiers in Oncology, BioMed Research International, Journal of Cancer and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.